Fibersol® (Digestion-Resistant Maltodextrin — ADM/Matsutani)

Evidence Level
Moderate
4 Clinical Trials
4 Documented Benefits
3/5 Evidence Score

Fibersol is a digestion-resistant maltodextrin, a soluble fiber sold by ADM and Matsutani. It is a palatable, low-viscosity fiber, so it mixes into drinks and foods without thickening them and is often used to raise their fiber content. Most of it passes the small intestine undigested, and part is fermented by gut bacteria in the colon. A pooled analysis of 37 placebo-controlled trials in healthy adults found that about 6 g taken with a carbohydrate meal lowered the post-meal blood sugar rise by roughly 10 to 20 percent. In a crossover study, 10 g with a meal delayed hunger for 1.5 to 2 hours, while 5 g did nothing. Two 12-week Japanese trials run with the maker found small drops in visceral (belly) fat at 15 to 27 g a day. Most of these studies had authors from the companies that make or sell it. Mild gas or bloating can occur at higher intakes.

Studied Dose Acute satiety and glycemic trials used 6 to 10 g per dose; the visceral-fat trials used 15 to 27 g per day in three divided doses.
Active Compound Digestion-resistant maltodextrin, a soluble dietary fiber that resists digestion and is partly fermented in the colon.

Benefits

Satiety and appetite

In a double-blind crossover study in 19 healthy adults, 10 g taken in tea with a meal delayed the return of hunger and kept people fuller for 1.5 to 2 hours, and raised the gut hormones PYY and GLP-1. A 5 g dose had no effect. Each test lasted about 4 hours, and body weight was not measured.

Supports healthy post-meal blood sugar

A meta-analysis of 37 placebo-controlled trials in healthy adults found that resistant maltodextrin taken with a carbohydrate food lowered the blood sugar rise, more with larger doses: about 20 percent for 6 g in a drink and about 10 percent when mixed into food. The maker funded the review, and one of its two authors worked there.

Gut bacteria and butyrate fermentation

In a 3-week double-blind study in 38 healthy adults, 7.5 or 15 g a day shifted fermentation in the colon toward butyrate and changed the mix of stool bacteria. Bifidobacteria only tended to rise, without reaching statistical significance, and digestive side effects were very minor.

Visceral fat and waist size

In two 12-week double-blind trials run with the maker, resistant maltodextrin taken three times a day reduced visceral (belly) fat on scans versus placebo. With 9 g doses, 30 adults with metabolic syndrome also lost waist size and had lower triglycerides; with 5 g doses, 140 healthy adults saw a small drop in fat area.

Mechanism of action

1

Low-viscosity soluble fiber

Resistant maltodextrin resists digestion in the small intestine. Unlike gel-forming fibers it dissolves without thickening, yet in pooled trials it still lowered the blood sugar rise when taken with a carbohydrate meal, especially in drinks.

2

Colonic fermentation

Part of the fiber is fermented by colon bacteria into short-chain fatty acids. In a 3-week study the mix shifted toward butyrate, the main fuel for cells lining the colon, and the balance of stool bacteria changed.

Clinical trials

1
Fibersol-2 and Hunger After a Meal: Randomized Crossover Study
PubMed

Randomized, double-blind, placebo-controlled crossover study: a standard meal with tea containing 0, 5 or 10 g of Fibersol-2, with appetite ratings every 30 minutes and gut hormones measured for 4 hours. One author worked for ADM. (Ye et al. 2015, Nutr Res)

19 healthy adults (9 men, 10 women).

10 g delayed hunger and increased fullness for 1.5 to 2 hours and raised PYY and GLP-1 compared with 0 or 5 g. The 5 g dose had no effect on hunger. Body weight was not studied.

2
Resistant Maltodextrin 9 g Three Times Daily in Metabolic Syndrome: 12-Week RCT
PubMed

Randomized, double-blind, placebo-controlled parallel trial: tea with 9 g resistant maltodextrin or placebo tea at each of three meals for 12 weeks. Four of the six authors worked for Matsutani, the maker. (Hashizume et al. 2012, J Nutr Sci Vitaminol (Tokyo))

30 adults with metabolic syndrome.

Waist circumference, visceral fat area, insulin resistance (HOMA-R) and triglycerides fell more over time than on placebo (time-by-treatment p = 0.044, 0.012, 0.032 and 0.049). Fasting glucose fell within the fiber group. The trial was small.

3
Resistant Maltodextrin 5 g Three Times Daily and Visceral Fat: 12-Week RCT
PubMed

Randomized, double-blind, placebo-controlled parallel trial of a drink with 5 g resistant maltodextrin or a placebo drink three times daily for 12 weeks, with CT scans of abdominal fat. Authors included employees of Matsutani and Coca-Cola Japan. (Kitagawa et al. 2020, J Nutr Sci Vitaminol (Tokyo))

140 healthy adults.

Visceral fat area fell in the fiber group from about 105 to 101 square centimeters and differed significantly from placebo (p < 0.05). No serious adverse events or abnormal blood or urine findings were seen.

4
Fibersol-2 and Gut Bacteria: 3-Week Randomized Study
PubMed

Randomized, double-blind study comparing 15 g/day maltodextrin, 7.5 g each of maltodextrin and Fibersol-2, or 15 g/day Fibersol-2 for a 3-week treatment period. (Fastinger et al. 2008, J Am Coll Nutr)

38 healthy adults.

Fibersol-2 shifted short-chain fatty acids in stool toward butyrate and changed bacterial populations from baseline. Bifidobacteria only tended to rise (p = 0.12). Effects on digestive tolerance were very minor.

Side effects and drug interactions

Common Potential side effects

Well tolerated at up to 15 g a day in a 3-week study, with only very minor digestive effects.
A 12-week trial of 15 g a day found no serious adverse events and no abnormal blood or urine findings.
Mild gas or bloating can occur as intake rises; increase the amount gradually.

Important Drug interactions

Diabetes medicines: resistant maltodextrin lowered the post-meal blood sugar rise in pooled trials, so check your blood sugar when you start it if you use glucose-lowering medicines.
Other oral medicines: fiber may affect how some drugs are absorbed; ask your pharmacist whether to space doses.
Tell your doctor if you have a digestive condition.

Frequently asked questions about Fibersol® (Digestion-Resistant Maltodextrin — ADM/Matsutani)

What is Fibersol?

Fibersol is a brand of digestion-resistant maltodextrin, a soluble fiber that mixes into drinks and foods without thickening them. Most of it is not digested in the small intestine, and part of it is fermented by bacteria in the colon.

What is Fibersol used for?

It is mainly used to add fiber to foods and drinks. In trials it lowered the blood sugar rise after carbohydrate meals, 10 g with a meal delayed hunger for a couple of hours, and two maker-run trials found small drops in belly fat over 12 weeks.

How much Fibersol was used in studies?

The blood sugar and appetite studies used about 6 to 10 g with a meal. The 12-week belly-fat trials used 5 or 9 g three times a day, which is 15 to 27 g a day.

Does Fibersol cause gas or bloating?

In a 3-week study at up to 15 g a day, digestive effects were very minor. Some people may notice mild gas or bloating at higher amounts, so increase gradually.

What is the recommended dosage of Fibersol?

The clinically studied dose is Acute satiety and glycemic trials used 6 to 10 g per dose; the visceral-fat trials used 15 to 27 g per day in three divided doses. Always follow the product label and check with a healthcare provider for personal advice.

Is Fibersol safe, and does it have side effects?

Side effects and cautions reported for Fibersol include: Well tolerated at up to 15 g a day in a 3-week study, with only very minor digestive effects. A 12-week trial of 15 g a day found no serious adverse events and no abnormal blood or urine findings. It may also interact with some medications. Fibersol is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Fibersol interact with any medications?

Possible interactions include: Diabetes medicines: resistant maltodextrin lowered the post-meal blood sugar rise in pooled trials, so check your blood sugar when you start it if you use glucose-lowering medicines. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Fibersol?

NutraSmarts rates the evidence for Fibersol as Moderate (3 out of 5). It is backed by 4 study summaries and 5 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(5 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Ye Z, Arumugam V, Haugabrooks E, Williamson P, Hendrich S. Soluble dietary fiber (Fibersol-2) decreased hunger and increased satiety hormones in humans when ingested with a meal. Nutr Res. 2015;35(5):393-400. doi: 10.1016/j.nutres.2015.03.004.PubMedUsed to support: Randomized double-blind placebo-controlled crossover trial in 19 healthy adults: 10 g of Fibersol-2 taken with a meal delayed hunger and increased fullness for 1.5 to 2 hours and raised the satiety hormones peptide YY and GLP-1, while 5 g had no effect. It measured appetite ratings and hormones, not body weight. One author worked for ADM, which sells the fiber.
  2. Livesey G, Tagami H. Interventions to lower the glycemic response to carbohydrate foods with a low-viscosity fiber (resistant maltodextrin): meta-analysis of randomized controlled trials. Am J Clin Nutr. 2009;89(1):114-25. doi: 10.3945/ajcn.2008.26842.PubMedUsed to support: Meta-analysis of 37 randomized placebo-controlled trials in healthy adults: about 6 g of resistant maltodextrin lowered the post-meal blood glucose rise by roughly 10 to 20 percent, dose-dependently, with a larger effect in drinks than in solid foods. The review was commissioned and funded by Matsutani, the maker of the fiber, and the second author worked there.
  3. Hashizume C, Kishimoto Y, Kanahori S, Yamamoto T, Okuma K, Yamamoto K. Improvement effect of resistant maltodextrin in humans with metabolic syndrome by continuous administration. J Nutr Sci Vitaminol (Tokyo). 2012;58(6):423-30. doi: 10.3177/jnsv.58.423.PubMedUsed to support: Randomized double-blind placebo-controlled trial in 30 adults with metabolic syndrome: 9 g of resistant maltodextrin taken three times daily for 12 weeks significantly reduced waist circumference, visceral fat area, insulin resistance (HOMA-R) and triglycerides versus placebo over time. Fasting glucose fell within the treatment group. The trial was small, and four of the six authors worked for Matsutani, the fiber's maker.
  4. Kitagawa M, Nakagawa S, Suzuki T, Kishimoto Y, Kanahori S, Hatakeyama Y, Tomita S, Fukuhara I. Visceral Fat-Reducing Effect and Safety of Continuous Consumption of Beverage Containing Resistant Maltodextrin: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial. J Nutr Sci Vitaminol (Tokyo). 2020;66(5):417-426. doi: 10.3177/jnsv.66.417.PubMedUsed to support: Randomized double-blind placebo-controlled trial in 140 healthy adults: 5 g of resistant maltodextrin three times daily for 12 weeks produced a small but significant fall in abdominal visceral fat area versus placebo, with no adverse blood or urine findings. Authors included employees of Matsutani, the fiber's maker, and of Coca-Cola Japan.
  5. Fastinger ND, Karr-Lilienthal LK, Spears JK, Swanson KS, Zinn KE, Nava GM, Ohkuma K, Kanahori S, Gordon DT, Fahey GC Jr. A novel resistant maltodextrin alters gastrointestinal tolerance factors, fecal characteristics, and fecal microbiota in healthy adult humans. J Am Coll Nutr. 2008;27(2):356-66. doi: 10.1080/07315724.2008.10719712.PubMedUsed to support: Randomized double-blind study in 38 healthy adults: Fibersol-2 was well tolerated and shifted colonic fermentation toward butyrate and altered fecal bacterial populations, tending to raise bifidobacteria, with only minor effects on digestive tolerance.